We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New FDA Analysis Finds More Trials Need to Meet Postmarketing Requirements
New FDA Analysis Finds More Trials Need to Meet Postmarketing Requirements
New data collection methods show more trials than previously thought need to meet their postmarketing requirements (PMR) and postmarketing commitments (PMC), a new FDA report says.